Quebec man had drug-resistant swine flu - Action News
Home WebMail Saturday, November 23, 2024, 06:33 PM | Calgary | -11.4°C | Regions Advertise Login | Our platform is in maintenance mode. Some URLs may not be available. |
Montreal

Quebec man had drug-resistant swine flu

A 60-year-old Quebec man is one of a handful of people around the world to have a strain of swine flu that is resistant to drugs.

A 60-year-old Quebec man is one of a handful of people around the world tohave a strain of swine flu that is resistant to drugs.

Health officials said the man likely contracted the virus from his son and did not require hospital treatment.

Canada's lead researchers are trying to find out more about what this means for the effectiveness of millions of doses of stockpiled antiviral drugs.

Dr. Guy Boivin,Canada Research Chair on emerging viruses and antiviral resistance in Quebec City, said Tuesday the new strains of drug-resistant swine fluraise a red flag butshould not scare anyone.

"We know the exact, specific mutation, and this is a mutation that has been reported before in human viruses that were resistant to Tamiflu, so it's not totally unexpected," said Boivin.

Boivin said he suspects the Quebec father was already infected when he was given a low preventive dose ofthe antiviral drug Tamiflu. Boivin suspected the fathers virus adapted to the drug at that point, becoming resistant.

Never in hospital

Boivin said the good news is that the father recovered well and was never taken to hospital.He said the next step is to find out how quickly the drug-resistant strain reproduces, and whether it's more potent and dangerous.

"We are using a lot of Tamiflu since [the] beginning of the pandemic, so using more antivirals probably means there is more chance of developing resistances," Boivin said.

Hesaid he'd also like to see a greater variety of antiviral drugs on the market, in case more people develop or contract a drug-resistant swine flu.

There are only two antiviral drugs currently available, and Tamiflu makes up 80 per cent of the 50 million doses reserved for Canadians.